Category: Insights

Inside the mind of an EPO examiner

This article was originally published by Philippe Lahorte in World Patent Information Volume 54, Supplement, September 2018, Pages S18-S22 Under a Creative Commons license. Abstract This article provides an insight…
The post Inside the mind of an EPO e…


DrugPatentWatch Partners with Adis: Helping Drug Companies Make Better Decisions

DrugPatentWatch, a provider of global biopharmaceutical business intelligence, has entered into a partnership with Adis. The partner will enhance Adis’ market-leading platform, bringing together the most relevant information to support…
The post DrugPa…


Branded Generics: What They Are and Why They’re Profitable

Branded generics are generic drugs that have been given proprietary brand names. They have a small, but profitable place in the U.S. pharmaceutical market.
The post Branded Generics: What They Are and Why They’re Profitable appeared first on DrugPatent…


How Pharmaceutical Life Cycle Management Strategies Are Evolving

Pharmaceutical life cycle management begins earlier and ends later to maximize stakeholder value in all phases of drug development.
The post How Pharmaceutical Life Cycle Management Strategies Are Evolving appeared first on DrugPatentWatch – Make Bette…


Is Patent “Evergreening” Restricting Access to Medicine/Device Combination Products?

This paper was originally published by Reed F. Beall, Jason W. Nickerson, Warren A. Kaplan, Amir Attaran in PLoS ONE 11(2): e0148939 under a Creative Commons Attribution License. Abstract Background…
The post Is Patent “Evergreening” Restricting Access…


Rising Drug Prices: How Healthcare Systems Are Coping

Healthcare systems including hospitals are taking care-related and business-related steps to cope with rapidly increasing drug prices.
The post Rising Drug Prices: How Healthcare Systems Are Coping appeared first on DrugPatentWatch – Make Better Decisi…


A ‘Netflix’ Model for Drug Pricing to Bring Treatments to More People

According to the Louisiana Department of Health, an estimated 500 people per year are infected with hepatitis C (HCV) in Louisiana. By 2016, the number of identified HCV cases in that state…
The post A ‘Netflix’ Model for Drug Pricing to Bring Treatmen…


Day 181 Generic Drug Launch – A Fast and Cheap Way to Find Generic Entry Opportunities

Successful drug patent challengers get 180 days of market protection The Food and Drug Administration rewards successful drug patent challengers by giving them 180 days of generic market exclusivity (see…
The post Day 181 Generic Drug Launch – A Fast a…


Do NOT follow this link or you will be banned from the site!